Clinical Trial Market Research Reports & Industry Analysis
Clinical Trial Industry Research & Market Reports
-
Clinical Trials Support Services Market
... & Biopharmaceutical Companies, Medical Device Companies, and Others), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Clinical trial support ... Read More
-
Frozen Shoulder Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
... Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of Frozen Shoulder Syndrome Clinical trials scenario. This report provides top line data relating to the ... Read More
-
Schizophrenia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
... Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of Schizophrenia Clinical trials scenario. This report provides top line data relating to the clinical trials on Schizophrenia. Report includes ... Read More
-
Ulcerative Colitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of Ulcerative Colitis Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
... Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) Clinical trials scenario. This report provides top line data ... Read More
-
Systemic Lupus Erythematosus Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
... Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of Systemic Lupus Erythematosus Clinical trials scenario. This report provides top line data relating to the ... Read More
-
Idiopathic Pulmonary Fibrosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
... Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of Idiopathic Pulmonary Fibrosis Clinical trials scenario. This report provides top line data relating to the ... Read More
-
Global Clinical Trial Imaging Market Report and Forecast 2023-2031
... clinical trials and advancements in imaging technologies. The market is expected to grow at a CAGR of 8.05% during the forecast period of 2023-2031 to attain a value of USD 2.5 billion by 2031. Clinical ... Read More
-
Clinical Trials Market Analysis and Forecast to 2032: By Phase (Phase I, Phase II, Phase III, and Phase III), Study Design (Interventional Study, Observational Study, and Expanded Access Study), Therapeutic Area (Autoimmune Disease, Oncology, Cardiology, and Others), and Region
... and Others), and Region A clinical trial is a research study that tests a new medical approach, device, medication, or other treatment. Clinical trials are used to determine whether new medical approaches are safe and ... Read More
-
Healthcare Cognitive Computing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 13.2 Billion by 2028, exhibiting a growth rate (CAGR) of 19% during 2023-2028. Cognitive computing is a self-learning system that relies on data mining techniques, pattern recognition, natural languages, human sense processing, and ... Read More
-
Clinical Trial Management Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... market to reach US$ 1,953.4 Million by 2028, exhibiting a growth rate (CAGR) of 11% during 2023-2028. The growing demand for efficient clinical trials, rising pressure from regulatory agencies to ensure compliance with regulations, and ... Read More
-
Pneumococcal Vaccines (PV) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... 148 million vaccinations for PV in the adult population for the 16 countries covered in GlobalData’s epidemiology forecast. Currently, there are seven leading marketed vaccines, with Merck & Co and Pfizer being key players in ... Read More
-
Viral Vector & Plasmid DNA Manufacturing Market by Type (Viral Vector (Retroviruses, Adenoviruses, AAV, Lentiviruses), Plasmid DNA), Workflow (Upstream, Downstream), Application (Cell & Gene Therapy), Diseases (Cancer), End User - Global Forecast to 2028
... global viral vector and plasmid DNA manufacturing market is projected to reach USD 12.8 billion by 2028 from USD 5.5 billion in 2023, at a CAGR of 18.2% during the forecast period of 2023 to ... Read More
-
Ophthalmic Clinical Trials Market Size, Share & Trends Analysis Report By Product (Devices, Drugs), By Phase (Discovery Phase, Preclinical Phase, Clinical Phase), By Indication, By Sponsor Type, By Region, And Segment Forecasts, 2023 - 2030
... Ophthalmic Clinical Trials Market Growth & Trends The global ophthalmic clinical trials market size is expected to reach USD 2.5 billion by 2030 at a CAGR of 6.6% over the forecast period, according to a ... Read More
-
IDC Perspective: Why Is 5G High on Pharma's Radar?
... the roadblocks lie and provides guidance to technology buyers."As 5G technology becomes increasingly pervasive, as patients go remote, and as the adoption of decentralized clinical trials continues to grow, the life science industry will increasingly ... Read More
-
Clinical Trials Supply & Logistics Market
... (Phase 0, Phase I, Phase II, Phase III), By Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Disorders, Others), By End User Industry (Pharmaceutical v/s Medical Devices), By Company and By Region The global clinical trials supply ... Read More
-
Viral Vector Production Market By Viral Vector Type (Adenoviral Vectors, Lentiviral Vectors, Retroviral Vectors, Adeno-Associated Viral Vectors, Other Viral Vectors), By Indication (Cancer, Genetic Disorders, Infectious Diseases, Other Diseases), By Application (Gene Therapy, Vaccinology): Global Opportunity Analysis and Industry Forecast, 2023-2032
... Opportunity Analysis and Industry Forecast, 2023-2032 The viral vector production market was valued for $1.1 billion in 2022 and is estimated to reach $6.1 billion by 2032, exhibiting a CAGR of 18.8% from 2023 to ... Read More
-
Medical Terminology Software Market By Application (Quality Reporting, Reimbursement, Data Aggregation, Clinical Trials, Others), By End User (Healthcare Providers, Healthcare Payers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
... was valued at $0.9 billion in 2022, and is projected to reach $2.6 billion by 2032, growing at a CAGR of 10.9% from 2023 to 2032.Medical terminology software is a specialized software that provides definitions, ... Read More
-
Reflux Esophagitis (Gastroesophageal Reflux Disease) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... more than 300 million prevalent cases of GERD in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast. The marketed drugs space for GERD comprises both novel class of potassium-competitive acid blockers (P-CABs) and ... Read More
-
Mpox (Monkeypox) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... in GlobalData’s epidemiology fact sheet, GlobalData epidemiologists estimated a total of 66,674 incident cases of mpox in 2022. Tecovirimat (Tpoxx) is the only approved medication for the treatment of severe complications of mpox that is ... Read More
-
Vertigo Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Vertigo Clinical trials scenario. This report provides top line data relating to the clinical trials on Vertigo. Report includes ... Read More
-
Renal Cell Carcinoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Renal Cell Carcinoma Clinical trials scenario. This report provides top line data relating to the ... Read More
-
Narcolepsy Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... prevalent cases of narcolepsy in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast. The majority of marketed drugs for the treatment of narcolepsy are transport inhibitors and receptor agonists. The narcolepsy pipeline consists ... Read More
-
Alpha-1 Antitrypsin Deficiency (A1AD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Alpha-1 Antitrypsin Deficiency (A1AD) Clinical trials scenario. This report provides top line data ... Read More
-
Hyperglycemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Hyperglycemia Clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperglycemia. Report includes ... Read More
Research Assistance
